Agilent to build new facility in Colorado, increasing pharmaceutical manufacturing capacity
Expansion will enable the company to more than double its commercial manufacturing capacity for nucleic acid APIs.
Agilent Technologies has acquired 20 acres in Weld County, Colorado, on which it plans to build a pharmaceutical manufacturing facility.
The expansion will enable the company to more than double its commercial manufacturing capacity for nucleic acid APIs.
"The products manufactured at this site will be used by our customers to improve the lives of patients suffering from a variety of diseases," said Skip Thune, general manager of the company's Nucleic Acids Solutions Division. "At Agilent, we are committed to meeting the ever-increasing needs of our customers for oligonucleotides."
Researchers believe oligonucleotides (short DNA and RNA molecules) hold the potential to treat various forms of cancer, diabetes, muscular dystrophy and other disorders.
Thune noted that the expansion would result in about 150 to 200 new, permanent high-paying jobs.
"Colorado is thrilled to welcome Agilent Technologies to the state," said Gov. John Hickenlooper. "This expansion will enhance Colorado's skilled workforce and dedication to research and development firms. We look forward to supporting Agilent's innovative work in our state."
"The Agilent project is a huge win for the Town of Frederick, Weld County and all of Northern Colorado," said Mike Freeman, chairman of the Weld County Commissioners. "The project adds diversification to our thriving economic base, plus significant new jobs and tax base. It also showcases what an amazing growth region Northern Colorado is due to the diverse workforce and business-friendly environment."
"The impact of new high-paying jobs and millions of dollars in investment will trigger a huge positive ripple through the local economy, pumping new revenue into everything from restaurants to housing," added Tony Carey, mayor of Frederick. "Winning this project shows the tremendous assets of Frederick and Weld County, and we welcome Agilent to our community."
"Local support paved the way for the Agilent project, and it's a great example of local governments working together to proactively accomplish a significant economic development project," said Tom Haren, chairman of the Upstate Colorado Economic Development Board.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance